Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.05
Bid: 1.00
Ask: 1.10
Change: 0.00 (0.00%)
Spread: 0.10 (10.00%)
Open: 1.05
High: 1.05
Low: 1.05
Prev. Close: 1.05
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

12 Dec 2011 07:00

RNS Number : 7431T
Microsaic Systems plc
12 December 2011
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

Trading update and directorate change

 

 

12th December 2011: Microsaic Systems plc (AIM: MSYS), a leading developer of chip-based scientific instruments today announces a directorate change and an update on trading.

The Company announces that Alan Finlay, CEO, has stepped down from the Board with immediate effect. Current Chairman Eric Yeatman has taken the post of acting CEO while the board identifies a suitable replacement. Colin Nicholl, the Company's Deputy Chairman, will serve as Chairman during this period. Alan will remain in the Company to advise and assist the Board during the transitional phase.

Since Microsaic Systems published its half year results on 26th September, the Company has continued to progress the commercialisation of its innovative chip-based mass spectrometry system - the Microsaic 3500 MiD - and has achieved notable success: as stated in September, relationships have been established with five potential OEM sales channels, with one unit being shipped. Since then a unit has been shipped to a second partner and it has received a positive initial technical evaluation. In addition, a major Asian instrumentation company has expressed interest in becoming an OEM - our 6th to-date; and Microsaic has delivered a 3500 MiD to a major European technical research organisation as part of its on-going European Commission-supported collaboration to develop a system for monitoring industrial bio-processes.

The implementation of the direct sales strategy is also going well. Since the delivery of a first system to a major international pharmaceutical company, which was reported in September, the Company has now received further orders for trial systems from two more international pharmaceutical clients.

Commenting on the news, Microsaic Acting CEO Eric Yeatman said:

"We are delighted to be updating the market with the news that our strategy is being validated by customers and partners. The attraction and uniqueness of our miniature chip-based mass spectrometry products is being recognised and our growing sales pipeline gives us confidence for the future.

The Board would like to take this opportunity to thank Alan for his very significant contribution to the development of the Company since joining over ten years ago, and recognises his vision, drive and hard work during his tenure as CEO."

Contacts

 

Microsaic Systems

Eric Yeatman, Acting CEO

 

Via Citigate Dewe Rogerson

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

+44 (0)20 7260 1000

Citigate Dewe Rogerson

Ginny Pulbrook, Chris Gardner, Mark Swallow

 

+44 (0)20 7282 2995/2948

+44 (0)7903 737703

 

 

About Microsaic Systems

 

Microsaic Systems develops micro-engineered scientific instruments for the identification of chemicals in liquids, gases and solids. Microsaic's technologies are based on the gold-standard technique of mass spectrometry (MS), which is currently based on large and expensive systems.

 

Microsaic is the first and only company to have successfully miniaturised MS onto patented chip-based technologies (ionchip®, spraychip® and vac-chip®) to create instruments that retain the speed and sensitivity of MS but are smaller, lighter, more energy efficient and cheaper to run than conventional MS systems.

 

MS technology is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London and was admitted to AIM in April 2011 under the ticker MSYS.

 

www.microsaic.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFFLFFFLFLFBX
Date   Source Headline
5th Mar 20197:00 amRNSInvestor Event
19th Feb 20197:00 amRNSNotice of Results
11th Jan 20197:00 amRNSNew Protein Identification Product
19th Dec 201811:20 amRNSBioprocessing partnership update & trading update
7th Nov 20187:00 amRNSExclusive US and Canada Distribution Agreement
3rd Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSNotice of Results
29th Jun 20184:12 pmRNSHolding(s) in Company
26th Jun 20182:04 pmRNSHolding(s) in Company
25th Jun 201810:10 amRNSDirectors' Interests
22nd Jun 201810:40 amRNSResult of GM, Completion of Fundraising & TVR
21st Jun 20187:00 amRNSDistribution Agreement with Amedis, spol. s ro.
13th Jun 20187:00 amRNSDistribution Agreement with Omicron Research Ltd.
6th Jun 20187:00 amRNSSuccessful Fundraising of £5.5 million
5th Jun 20184:46 pmRNSPrimaryBid.com Offer
5th Jun 20184:45 pmRNSFundraising
24th May 20187:00 amRNSDistribution Agreement with Stable Arm Sdn. Bhd.
9th May 20187:00 amRNSAgreement with Rightek Co., Ltd.
4th May 201811:25 amRNSResult of AGM
4th May 20187:00 amRNSAGM Statement
12th Apr 20187:00 amRNSMicrosaic signs Agreement with Knauer
6th Apr 20187:00 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20187:00 amRNSAgreement with Unimicro Technologies Inc.
23rd Mar 20184:45 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSCommercial contract with CPI Innovation Services
5th Mar 20187:00 amRNSFinal Results
21st Feb 20187:00 amRNSNotice of Results
3rd Jan 20187:00 amRNSAward of Options
19th Dec 20177:00 amRNSDirectorate Change
13th Dec 20177:00 amRNSResearch agreement with global biopharma partner
28th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSAppointment of CEO
13th Sep 20177:00 amRNSMicrosaic to Exhibit at BioProcess International
14th Aug 20177:00 amRNSNotice of Results
19th Jun 20177:00 amRNSTrading Statement
15th May 201711:42 amRNSResult of AGM
11th May 20177:00 amRNSMicrosaic Enhances Bioprocessing Capabilities
26th Apr 20177:00 amRNSIntegration with SCPA chromatography software
21st Apr 20177:00 amRNSNotice of AGM
7th Apr 20177:00 amRNSAgreement
21st Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSChange of registrar
24th Jan 201712:56 pmRNSAppointment of Interim Chairman
13th Dec 20167:00 amRNSTrading Statement
28th Sep 20167:00 amRNSDirectorate Change
21st Sep 20164:39 pmRNSHolding(s) in Company
16th Sep 20161:44 pmRNSDirector/PDMR Shareholding
15th Sep 20161:03 pmRNSHolding(s) in Company
15th Sep 201610:02 amRNSTR-1: Notification of Major Interest in Shares
14th Sep 20165:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.